(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide

C62H97NO3 — CID 164509871

IUPAC(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NC(CO)C(O)/C=C/CC/C=C/CC/C=C/CCCCCCCCC
InChIInChI=1S/C62H97NO3/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-40-42-44-46-48-50-52-54-56-58-62(66)63-60(59-64)61(65)57-55-53-51-49-47-45-43-41-20-18-16-14-12-10-8-6-4-2/h5,7,11,13,17,19-20,22-23,25-26,28-29,31-32,34-35,37-38,40-42,46-49,55,57,60-61,64-65H,3-4,6,8-10,12,14-16,18,21,24,27,30,33,36,39,43-45,50-54,56,58-59H2,1-2H3,(H,63,66)/b7-5-,13-11-,19-17-,23-22-,26-25-,29-28-,32-31-,35-34-,38-37-,41-20+,42-40-,48-46-,49-47+,57-55+
InChIKeyZYRCLUOOGYGFRD-BWDNZRCRSA-N
MW904.46 g/mol
LogP17.57
Rot. Bonds45

About (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide (PubChem CID 164509871) has the molecular formula C62H97NO3 and a molecular weight of 904.46 g/mol. Its IUPAC name is (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide.

Molecular Properties

Compound Name(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide
PubChem CID164509871
Molecular FormulaC62H97NO3
Molecular Weight904.46 g/mol
Exact Mass903.75
IUPAC Name(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NC(CO)C(O)/C=C/CC/C=C/CC/C=C/CCCCCCCCC
InChIInChI=1S/C62H97NO3/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-40-42-44-46-48-50-52-54-56-58-62(66)63-60(59-64)61(65)57-55-53-51-49-47-45-43-41-20-18-16-14-12-10-8-6-4-2/h5,7,11,13,17,19-20,22-23,25-26,28-29,31-32,34-35,37-38,40-42,46-49,55,57,60-61,64-65H,3-4,6,8-10,12,14-16,18,21,24,27,30,33,36,39,43-45,50-54,56,58-59H2,1-2H3,(H,63,66)/b7-5-,13-11-,19-17-,23-22-,26-25-,29-28-,32-31-,35-34-,38-37-,41-20+,42-40-,48-46-,49-47+,57-55+
InChIKeyZYRCLUOOGYGFRD-BWDNZRCRSA-N
XLogP17.57
TPSA69.56 Ų
H-Bond Donors3
H-Bond Acceptors3
Rotatable Bonds45
Heavy Atoms66
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500904.46
LogP ≤ 517.57
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxytricosa-4,8,12-trien-2-yl]tetratriaconta-16,19,22,25,28,31-hexaenamide
CID 164502358
(27Z,30Z,33Z,36Z,39Z)-N-[(4E,8E)-1,3-dihydroxyheptatriaconta-4,8-dien-2-yl]dotetraconta-27,30,33,36,39-pentaenamide
CID 164502333
(16Z,19Z,22Z,25Z)-N-[(4E,8E,12E)-1,3-dihydroxyhentriaconta-4,8,12-trien-2-yl]octacosa-16,19,22,25-tetraenamide
CID 164502155
(18Z,21Z)-N-[(4E,8E,12E)-1,3-dihydroxynonacosa-4,8,12-trien-2-yl]tetracosa-18,21-dienamide
CID 138186432
(14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]octatriaconta-14,17,20,23,26,29,32,35-octaenamide
CID 164501204
(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-[(4E,8E)-1,3-dihydroxyhenicosa-4,8-dien-2-yl]dotetraconta-12,15,18,21,24,27,30,33,36,39-decaenamide
CID 164501386
(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide
CID 164500380
(18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-[(4E,8E)-1,3-dihydroxyhexacosa-4,8-dien-2-yl]dotetraconta-18,21,24,27,30,33,36,39-octaenamide
CID 164509673
(17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E,12E)-1,3-dihydroxytetracosa-4,8,12-trien-2-yl]tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide
CID 164505653
(18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxyheptacos-4-en-2-yl]hexatriaconta-18,21,24,27,30,33-hexaenamide
CID 164506357
(7Z,10Z,13Z,16Z,19Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]docosa-7,10,13,16,19-pentaenamide
CID 164503239
(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(E)-1,3-dihydroxynonadec-4-en-2-yl]tetratriaconta-10,13,16,19,22,25,28,31-octaenamide
CID 164502093

Frequently Asked Questions

What is the IUPAC name of (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide?
The IUPAC name of (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide (CID 164509871) is (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide.
What is the SMILES notation for (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide?
The canonical SMILES for (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide is CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NC(CO)C(O)/C=C/CC/C=C/CC/C=C/CCCCCCCCC.
What is the InChIKey of (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide?
The InChIKey is ZYRCLUOOGYGFRD-BWDNZRCRSA-N. The full InChI is InChI=1S/C62H97NO3/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-40-42-44-46-48-50-52-54-56-58-62(66)63-60(59-64)61(65)57-55-53-51-49-47-45-43-41-20-18-16-14-12-10-8-6-4-2/h5,7,11,13,17,19-20,22-23,25-26,28-29,31-32,34-35,37-38,40-42,46-49,55,57,60-61,64-65H,3-4,6,8-10,12,14-16,18,21,24,27,30,33,36,39,43-45,50-54,56,58-59H2,1-2H3,(H,63,66)/b7-5-,13-11-,19-17-,23-22-,26-25-,29-28-,32-31-,35-34-,38-37-,41-20+,42-40-,48-46-,49-47+,57-55+.
What are the key properties of (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide?
(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide has a molecular weight of 904.46 g/mol, XLogP of 17.57, 45 rotatable bonds, 3 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide is sourced from PubChem (CID 164509871), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).